- Report
- November 2025
- 101 Pages
Europe
From €3551EUR$3,950USD£3,045GBP
- Report
- November 2025
- 75 Pages
Africa, Middle East
From €3102EUR$3,450USD£2,659GBP
- Report
- November 2025
- 89 Pages
North America
From €3102EUR$3,450USD£2,659GBP
- Report
- February 2026
- 150 Pages
United States
From €4361EUR$4,850USD£3,738GBP
- Report
- April 2026
- 120 Pages
Europe
From €3236EUR$3,599USD£2,774GBP
- Report
- August 2024
- 158 Pages
Global
From €1207EUR$1,390USD£1,000GBP
- Report
- March 2025
- 266 Pages
Global
From €4315EUR$4,799USD£3,699GBP
- Report
- April 2025
- 469 Pages
Global
From €4451EUR$4,950USD£3,815GBP
- Report
- September 2022
- 342 Pages
Global
From €4451EUR$4,950USD£3,815GBP
- Report
- March 2025
- 137 Pages
Global
From €3147EUR$3,500USD£2,698GBP
- Report
- June 2026
- 120 Pages
Mexico
From €2696EUR$2,999USD£2,312GBP
- Report
- August 2025
- 200 Pages
Global
From €2239EUR$2,490USD£1,919GBP
- Report
- January 2023
- 115 Pages
Global
From €5350EUR$5,950USD£4,586GBP
- Report
- July 2024
- 185 Pages
Global
From €4046EUR$4,500USD£3,468GBP
- Report
- July 2024
- 182 Pages
Global
From €4046EUR$4,500USD£3,468GBP
- Report
- September 2024
- 132 Pages
North America
From €3596EUR$4,000USD£3,083GBP
- Report
- February 2025
- 70 Pages
Argentina
From €3147EUR$3,500USD£2,698GBP
- Report
- September 2024
- 133 Pages
Europe
From €3596EUR$4,000USD£3,083GBP
- Report
- October 2023
- 190 Pages
Global
From €4046EUR$4,500USD£3,468GBP
- Report
- July 2024
- 150 Pages
Global
From €3372EUR$3,750USD£2,890GBP

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more